
Steven Lim
Supervisory Patent Examiner (ID: 9237, Phone: (571)270-1210 , Office: P/2686 )
| Most Active Art Unit | 2617 |
| Art Unit(s) | 2684, 2617, 2686, 2646, 2688 |
| Total Applications | 290 |
| Issued Applications | 187 |
| Pending Applications | 20 |
| Abandoned Applications | 88 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6581005
[patent_doc_number] => 20100291071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'Antibody Specific Binding to A-Beta Oligomer and the Use'
[patent_app_type] => utility
[patent_app_number] => 12/533294
[patent_app_country] => US
[patent_app_date] => 2009-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 24465
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20100291071.pdf
[firstpage_image] =>[orig_patent_app_number] => 12533294
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/533294 | Antibody Specific Binding to A-Beta Oligomer and the Use | Jul 30, 2009 | Abandoned |
Array
(
[id] => 6252060
[patent_doc_number] => 20100028357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'Antibodies That Specifically Bind to Abeta Oligomers and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/533348
[patent_app_country] => US
[patent_app_date] => 2009-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 28005
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028357.pdf
[firstpage_image] =>[orig_patent_app_number] => 12533348
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/533348 | Antibodies that specifically bind to Aβ oligomers and uses thereof | Jul 30, 2009 | Issued |
Array
(
[id] => 6142230
[patent_doc_number] => 20110129488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'IMMUNOTHERAPY COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF AMYLOIDOSIS'
[patent_app_type] => utility
[patent_app_number] => 13/056459
[patent_app_country] => US
[patent_app_date] => 2009-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 22725
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129488.pdf
[firstpage_image] =>[orig_patent_app_number] => 13056459
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/056459 | IMMUNOTHERAPY COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF AMYLOIDOSIS | Jul 27, 2009 | Abandoned |
Array
(
[id] => 11358428
[patent_doc_number] => 09535076
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'Methods and compositions for eliciting an amyloid-selective immune response'
[patent_app_type] => utility
[patent_app_number] => 13/055899
[patent_app_country] => US
[patent_app_date] => 2009-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 21446
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13055899
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/055899 | Methods and compositions for eliciting an amyloid-selective immune response | Jul 26, 2009 | Issued |
Array
(
[id] => 5490826
[patent_doc_number] => 20090291897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-26
[patent_title] => 'METHODS FOR TREATING UNWANTED WEIGHT LOSS OR EATING DISORDERS BY ADMINISTERING A TRKB AGONIST'
[patent_app_type] => utility
[patent_app_number] => 12/508379
[patent_app_country] => US
[patent_app_date] => 2009-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 30578
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20090291897.pdf
[firstpage_image] =>[orig_patent_app_number] => 12508379
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/508379 | METHODS FOR TREATING UNWANTED WEIGHT LOSS OR EATING DISORDERS BY ADMINISTERING A TRKB AGONIST | Jul 22, 2009 | Abandoned |
Array
(
[id] => 6372706
[patent_doc_number] => 20100080800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'Humanized antibody'
[patent_app_type] => utility
[patent_app_number] => 12/460747
[patent_app_country] => US
[patent_app_date] => 2009-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 38610
[patent_no_of_claims] => 152
[patent_no_of_ind_claims] => 132
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20100080800.pdf
[firstpage_image] =>[orig_patent_app_number] => 12460747
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/460747 | Methods of treating amyloidosis with humanized anti-beta-amyloid antibodies | Jul 22, 2009 | Issued |
Array
(
[id] => 6252024
[patent_doc_number] => 20100028353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'ANTI-AMYLOID IMMUNOGENIC COMPOSITIONS, METHODS AND USES'
[patent_app_type] => utility
[patent_app_number] => 12/503490
[patent_app_country] => US
[patent_app_date] => 2009-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5073
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028353.pdf
[firstpage_image] =>[orig_patent_app_number] => 12503490
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/503490 | ANTI-AMYLOID IMMUNOGENIC COMPOSITIONS, METHODS AND USES | Jul 14, 2009 | Abandoned |
Array
(
[id] => 6351718
[patent_doc_number] => 20100021938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'Diagnosis and Prediction of Alzheimer\'s Disease'
[patent_app_type] => utility
[patent_app_number] => 12/502476
[patent_app_country] => US
[patent_app_date] => 2009-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 18260
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20100021938.pdf
[firstpage_image] =>[orig_patent_app_number] => 12502476
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/502476 | Diagnosis and Prediction of Alzheimer's Disease | Jul 13, 2009 | Abandoned |
Array
(
[id] => 6347815
[patent_doc_number] => 20100021384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'USE OF VHH ANTIBODIES FOR THE PREPARATION OF PEPTIDE VECTORS FOR DELIVERING A SUBSTANCE OF INTEREST AND THEIR APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/501094
[patent_app_country] => US
[patent_app_date] => 2009-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9254
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20100021384.pdf
[firstpage_image] =>[orig_patent_app_number] => 12501094
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/501094 | VHH antibodies used as peptide vectors for delivering a substance of interest | Jul 9, 2009 | Issued |
Array
(
[id] => 6348738
[patent_doc_number] => 20100021478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'DIAGNOSTIC ANTIBODY ASSAY'
[patent_app_type] => utility
[patent_app_number] => 12/500940
[patent_app_country] => US
[patent_app_date] => 2009-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 19293
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20100021478.pdf
[firstpage_image] =>[orig_patent_app_number] => 12500940
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/500940 | Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptides | Jul 9, 2009 | Issued |
Array
(
[id] => 5958422
[patent_doc_number] => 20110182809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'Method of Promoting Neurogenesis'
[patent_app_type] => utility
[patent_app_number] => 13/003245
[patent_app_country] => US
[patent_app_date] => 2009-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 40867
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20110182809.pdf
[firstpage_image] =>[orig_patent_app_number] => 13003245
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/003245 | Method of Promoting Neurogenesis | Jul 8, 2009 | Abandoned |
Array
(
[id] => 7540563
[patent_doc_number] => 08058406
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-15
[patent_title] => 'Composition comprising antibodies to LINGO or fragments thereof'
[patent_app_type] => utility
[patent_app_number] => 12/500472
[patent_app_country] => US
[patent_app_date] => 2009-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 23
[patent_no_of_words] => 55378
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/058/08058406.pdf
[firstpage_image] =>[orig_patent_app_number] => 12500472
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/500472 | Composition comprising antibodies to LINGO or fragments thereof | Jul 8, 2009 | Issued |
Array
(
[id] => 7484520
[patent_doc_number] => 20110250211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'VARIABLE DOMAINS OF CAMELID HEAVY-CHAIN ANTIBODIES DIRECTED AGAINST GLIAL FIBRILLARY ACIDIC PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/002910
[patent_app_country] => US
[patent_app_date] => 2009-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11955
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20110250211.pdf
[firstpage_image] =>[orig_patent_app_number] => 13002910
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/002910 | Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins | Jul 6, 2009 | Issued |
Array
(
[id] => 6095381
[patent_doc_number] => 20110002949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'VACCINE FOR THE TREATMENT OF ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/496823
[patent_app_country] => US
[patent_app_date] => 2009-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6836
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20110002949.pdf
[firstpage_image] =>[orig_patent_app_number] => 12496823
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/496823 | VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE | Jul 1, 2009 | Abandoned |
Array
(
[id] => 5958541
[patent_doc_number] => 20110182928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'VACCINE AGAINST AMYLOID FOLDING INTERMEDIATE'
[patent_app_type] => utility
[patent_app_number] => 13/002174
[patent_app_country] => US
[patent_app_date] => 2009-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8945
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20110182928.pdf
[firstpage_image] =>[orig_patent_app_number] => 13002174
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/002174 | Vaccine against amyloid folding intermediate | Jun 30, 2009 | Issued |
Array
(
[id] => 8270158
[patent_doc_number] => 08211661
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-03
[patent_title] => 'Method for identifying individuals having a pervasive development disorder amenable to digestive enzyme therapy'
[patent_app_type] => utility
[patent_app_number] => 12/487864
[patent_app_country] => US
[patent_app_date] => 2009-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 5484
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12487864
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/487864 | Method for identifying individuals having a pervasive development disorder amenable to digestive enzyme therapy | Jun 18, 2009 | Issued |
Array
(
[id] => 9250153
[patent_doc_number] => 08613931
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-24
[patent_title] => 'Compounds for treating beta-amyloidoses'
[patent_app_type] => utility
[patent_app_number] => 12/997674
[patent_app_country] => US
[patent_app_date] => 2009-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 19
[patent_no_of_words] => 11484
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 511
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12997674
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/997674 | Compounds for treating beta-amyloidoses | Jun 11, 2009 | Issued |
Array
(
[id] => 6187864
[patent_doc_number] => 20110171243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'COMPOUNDS FOR TREATING AMYLOIDOSES'
[patent_app_type] => utility
[patent_app_number] => 12/997673
[patent_app_country] => US
[patent_app_date] => 2009-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8727
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20110171243.pdf
[firstpage_image] =>[orig_patent_app_number] => 12997673
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/997673 | Compounds for treating amyloidoses | Jun 11, 2009 | Issued |
Array
(
[id] => 8317087
[patent_doc_number] => 08231862
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-31
[patent_title] => 'RBP4 in insulin sensitivity/resistance, diabetes, and obesity'
[patent_app_type] => utility
[patent_app_number] => 12/455324
[patent_app_country] => US
[patent_app_date] => 2009-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 54
[patent_no_of_words] => 13111
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12455324
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/455324 | RBP4 in insulin sensitivity/resistance, diabetes, and obesity | May 31, 2009 | Issued |
Array
(
[id] => 5958561
[patent_doc_number] => 20110182948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'METHOD FOR TREATING DISEASE CHARACTERIZED BY PLAQUE'
[patent_app_type] => utility
[patent_app_number] => 12/993393
[patent_app_country] => US
[patent_app_date] => 2009-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7722
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20110182948.pdf
[firstpage_image] =>[orig_patent_app_number] => 12993393
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/993393 | METHOD FOR TREATING DISEASE CHARACTERIZED BY PLAQUE | May 21, 2009 | Abandoned |